Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-07-25FDA Approved: LITHIUM CARBONATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for Lithium Carbonate from Glenmark Pharmaceuticals Inc., USA. The approval likely updates label…
-
FDA approval · 2012-07-19FDA Approved: EPITOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for EPITOL (carbamazepine) from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2012-06-19FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved a supplemental application for carbamazepine from Torrent Pharmaceuticals Limited. This represents a supplemental approval …
-
FDA approval · 2012-06-19FDA Approved: OLANZAPINE AND FLUOXETINE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved the original application for a fixed-dose combination of olanzapine and fluoxetine (olanzapine/fluoxetine) by Teva Pharmaceutic…
-
FDA approval · 2012-06-19FDA Approved: CARBAMAZEPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Carbamazepine from Torrent Pharmaceuticals Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-05-31FDA Approved: LAMOTRIGINE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for lamotrigine from Glenmark Pharmaceuticals Inc., authorizing changes to the approved product.
-
FDA approval · 2012-05-21FDA Approved: LAMOTRIGINE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for lamotrigine filed by Unichem Pharmaceuticals (USA), Inc.
-
FDA approval · 2012-05-18FDA Approved: LAMOTRIGINE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approves a supplemental application for Lamotrigine from Alembic Pharmaceuticals Limited, granting approval of a generic lamotrigine pro…
-
FDA approval · 2012-04-30FDA Approved: RISPERIDONE — Supplemental Application (Amici Pharma, Inc.)
FDA approved a supplemental application for RISPERIDONE from Amici Pharma, Inc.
-
FDA approval · 2012-04-25FDA Approved: LAMOTRIGINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for lamotrigine by Aurobindo Pharma Limited. This action approves changes to the generic lamotri…
-
FDA approval · 2012-04-23FDA Approved: OLANZAPINE — Original Application (Torrent Pharmaceuticals Limited)
The FDA approved Torrent Pharmaceuticals Limited's original application for a generic olanzapine product, making a generic antipsychotic ava…
-
FDA approval · 2012-04-23FDA Approved: OLANZAPINE — Original Application (Dr. Reddy's Laboratories Ltd.)
FDA approves Dr. Reddy's Laboratories' generic olanzapine under an Original Abbreviated New Drug Application (ANDA).
-
FDA approval · 2012-04-23FDA Approved: OLANZAPINE — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approved Dr. Reddy's Laboratories' original application for olanzapine, enabling a generic version of the antipsychotic.
-
FDA approval · 2012-04-23FDA Approved: OLANZAPINE — Original Application (Aurobindo Pharma Limited)
FDA approved the Original Application for a generic olanzapine product from Aurobindo Pharma Limited.
-
FDA approval · 2012-04-23FDA Approved: OLANZAPINE — Original Application (Apotex Corp.)
The FDA approved Apotex Corp.'s generic olanzapine under an original ANDA. This marks approval of a generic version of olanzapine.
-
FDA approval · 2012-03-27FDA Approved: LAMOTRIGINE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a supplemental application for a Lamotrigine product from Unichem Pharmaceuticals (USA), Inc., effectively approving a gene…
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's generic quetiapine tablets through an Original Application. Quetiapine is approved for schizophrenia, bipolar disorder, …
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE — Original Application (Accord Healthcare Inc.)
FDA approved a generic Quetiapine product from Accord Healthcare Inc. under ANDA202152 (Original Application).
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE FUMARATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved the original application for a generic version of quetiapine fumarate from Sun Pharmaceutical Industries.
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE FUMARATE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s original-application generic quetiapine fumarate, a generic version of the antipsychotic queti…
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE FUMARATE — Original Application (BluePoint Laboratories)
FDA approved the original application for quetiapine fumarate as a generic drug, with BluePoint Laboratories listed as the applicant.
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE FUMARATE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s generic quetiapine fumarate (ANDA 090120) via an Original Application approval. The generic is…
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE FUMARATE — Original Application (Aurobindo Pharma Limited)
The FDA approved an original application for a generic quetiapine fumarate from Aurobindo Pharma Limited. This adds a generic option for the…
-
FDA approval · 2012-03-26FDA Approved: LAMOTRIGINE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for lamotrigine from Glenmark Pharmaceuticals (ANDA 079099).
-
FDA approval · 2012-03-22FDA Approved: ZIPRASIDONE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for ZIPRASIDONE submitted by Dr. Reddy's Laboratories Limited.